1. Home
  2. DVA vs DRS Comparison

DVA vs DRS Comparison

Compare DVA & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • DRS
  • Stock Information
  • Founded
  • DVA 1994
  • DRS 1969
  • Country
  • DVA United States
  • DRS United States
  • Employees
  • DVA N/A
  • DRS N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • DRS Military/Government/Technical
  • Sector
  • DVA Health Care
  • DRS Industrials
  • Exchange
  • DVA Nasdaq
  • DRS Nasdaq
  • Market Cap
  • DVA 9.4B
  • DRS 11.0B
  • IPO Year
  • DVA 1995
  • DRS N/A
  • Fundamental
  • Price
  • DVA $126.99
  • DRS $39.87
  • Analyst Decision
  • DVA Hold
  • DRS Strong Buy
  • Analyst Count
  • DVA 3
  • DRS 7
  • Target Price
  • DVA $151.00
  • DRS $46.43
  • AVG Volume (30 Days)
  • DVA 634.2K
  • DRS 923.8K
  • Earning Date
  • DVA 10-29-2025
  • DRS 10-29-2025
  • Dividend Yield
  • DVA N/A
  • DRS 0.92%
  • EPS Growth
  • DVA 8.72
  • DRS 32.60
  • EPS
  • DVA 10.20
  • DRS 0.94
  • Revenue
  • DVA $13,161,328,000.00
  • DRS $3,421,000,000.00
  • Revenue This Year
  • DVA $5.96
  • DRS $11.84
  • Revenue Next Year
  • DVA $3.54
  • DRS $6.72
  • P/E Ratio
  • DVA $12.35
  • DRS $41.89
  • Revenue Growth
  • DVA 5.09
  • DRS 11.43
  • 52 Week Low
  • DVA $122.93
  • DRS $27.87
  • 52 Week High
  • DVA $179.60
  • DRS $49.31
  • Technical
  • Relative Strength Index (RSI)
  • DVA 43.89
  • DRS 36.27
  • Support Level
  • DVA $124.60
  • DRS $39.00
  • Resistance Level
  • DVA $127.92
  • DRS $44.13
  • Average True Range (ATR)
  • DVA 2.70
  • DRS 1.33
  • MACD
  • DVA -0.05
  • DRS -0.64
  • Stochastic Oscillator
  • DVA 33.90
  • DRS 12.09

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: